TREATMENT OF LYMPHEDEMA USING PROTEOLYTIC AGENTS

摘要

The technology relates to the use of a proteolytic enzyme, for example hyaluronidase, for the treatment of abnormal protein collection in a patient's lymphatic system. In addition, the present technology provides a composition and a combined preparation each comprising hyaluronidase and at least one further proteolytic enzyme, and a method of prevention and/or treating primary or secondary edema in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.

主权项

1. A method of treating lymphedema in a subject in need of such treatment, comprising administering at least one proteolytic enzyme to deep tissue and applying pressure to the affected area, wherein the lymphedema is treated.